Literature DB >> 18761888

Epidemiological and virological assessment of influenza activity in Europe, during the 2006-2007 winter.

J M S Arkema1, A Meijer, T J Meerhoff, J Van Der Velden, W J Paget.   

Abstract

Influenza surveillance in Europe is based on influenza surveillance networks that cooperate and share information through the European Influenza Surveillance Scheme (EISS). EISS collected clinical and virological data on influenza in 33 countries during the 2006-2007 winter. Influenza activity started around 1 January and first occurred in Greece, Scotland and Spain. It then moved gradually across Europe from south to north and lasted until the end of March. In 29 out of 33 countries, the consultation rates for influenza-like-illness or acute respiratory infections in the winter of 2006-2007 were similar or somewhat higher than in the 2005-2006 winter. The highest consultation rates for influenzal ike-illness were generally observed among children aged 0-4 years and 5-14 years. The predominant virus strain was influenza A (97% of total detections) of the H3 subtype (93% of H-subtyped A viruses; 7% were A(H1)). The influenza A(H3) and A(H1) viruses were similar to the vaccine reference strains for the 2006-2007 season, A/Wisconsin/67/2005 (H3N2) and A/New Caledonia/20/99 (H1N1) respectively. The majority of the influenza B viruses were similar to the reference strain B/Malaysia/2506/2004, included in the 2006-2007 vaccine. In conclusion, the 2006-2007 influenza season in Europe was characterised by moderate clinical activity, a south to north spread pattern across Europe, and a dominance of influenza A(H3). Overall there was a good match between the vaccine virus strains and the reported virus strains.

Entities:  

Mesh:

Year:  2008        PMID: 18761888     DOI: 10.2807/ese.13.34.18958-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  8 in total

1.  Mortality in Spain in the Context of the Economic Crisis and Austerity Policies.

Authors:  Enrique Regidor; Alberto Mateo; Gregorio Barrio; Luis de la Fuente
Journal:  Am J Public Health       Date:  2019-05-16       Impact factor: 9.308

Review 2.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

3.  Influenza seasonality and predominant subtypes of influenza virus in Guangdong, China, 2004-2012.

Authors:  Jinyan Lin; Min Kang; Haojie Zhong; Xin Zhang; Fen Yang; Hangzhong Ni; Ping Huang; Teng Hong; Changwen Ke; Jianfeng He
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

4.  The geographic synchrony of seasonal influenza: a waves across Canada and the United States.

Authors:  Dena L Schanzer; Joanne M Langley; Trevor Dummer; Samina Aziz
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

5.  Quantifying the role of weather on seasonal influenza.

Authors:  Marion Roussel; Dominique Pontier; Jean-Marie Cohen; Bruno Lina; David Fouchet
Journal:  BMC Public Health       Date:  2016-05-26       Impact factor: 3.295

6.  The spatiotemporal characteristics of influenza A and B in the WHO European Region: can one define influenza transmission zones in Europe?

Authors:  Saverio Caini; Wladimir J Alonso; Clotilde El-Guerche Séblain; François Schellevis; John Paget
Journal:  Euro Surveill       Date:  2017-08-31

7.  Susceptibility of influenza A(H1N1)/pdm2009, seasonal A(H3N2) and B viruses to Oseltamivir in Guangdong, China between 2009 and 2014.

Authors:  Shan-Shan Liu; Xiao-Yang Jiao; Sheng Wang; Wen-Zhe Su; Ling-Zhi Jiang; Xin Zhang; Chang-Wen Ke; Ping Xiong
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

8.  Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003-2013.

Authors:  Anne Mosnier; Saverio Caini; Isabelle Daviaud; Jean-Louis Bensoussan; Françoise Stoll-Keller; Tan Tai Bui; Bruno Lina; Sylvie Van der Werf; Jean Marie Cohen
Journal:  BMC Infect Dis       Date:  2015-08-21       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.